Parameter
| Biomarker | CRNDE | Full name | Colorectal Neoplasia Differentially Expressed | Molecular Type | Nucleic acid (lncRNA) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis and prediction of treatment response | ||
| Disease | Acute Myeloid Leukemia (AML) | Disease Subtypes | / | ||
| Organ | Blood, bone marrow | Test Sample / Technology Platform | Blood/Bone marrow (real-time quantitative polymerase chain reaction, qRT-PCR) | ||
| Pathobiological Mechanisms | Downregulation of expression reduces the complete response rate, shortens the event-free survival (EFS) and overall survival (OS) | ||||
| Clinical Availability Status | Research verification: clinical data from 200 newly diagnosed AML patients supports. | ||||
| Notes and Dynamics | The prognostic value is more significant in cytogenetically normal AML and non-t(15;17) AML. | ||||